Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
Neurocrit Care ; 2024 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-39117963

RESUMEN

BACKGROUND: This study aimed to analyze the current status of brain death/death by neurologic criteria (BD/DNC) determination in Korea over a decade, identifying key areas for improvement in the process. METHODS: We conducted a retrospective analysis of data from the Korea Organ Donation Agency spanning 2011 to 2021, focusing on donors whose donations were not completed. The study reviewed demographics, medical settings, diagnoses, and outcomes, with particular emphasis on cases classified as nonbrain death and those resulting in death by cardiac arrest during the BD/DNC assessment. RESULTS: Of the 5047 patients evaluated for potential brain death from 2011 to 2021, 361 were identified as noncompleted donors. The primary reasons for noncompletion included nonbrain death (n = 68, 18.8%), cardiac arrests during the BD/DNC assessment process (n = 80, 22.2%), organ ineligibility (n = 151, 41.8%), and logistical and legal challenges (n = 62, 17.2%). Notably, 25 (36.8%) of them failed to meet the minimum clinical criteria, and 7 of them were potential cases of disagreement between the two clinical examinations. Additionally, most cardiac arrests (n = 44, 55.0%) occurred between the first and second examinations, indicating management challenges in critically ill patients during the assessment period. CONCLUSIONS: Our study highlights significant challenges in the BD/DNC determination process, including the need for improved consistency in neurologic examinations and the management of critically ill patients. The study underscores the importance of refining protocols and training to enhance the accuracy and reliability of brain death assessments, while also ensuring streamlined and effective organ donation practices.

2.
Chemistry ; 29(36): e202300903, 2023 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-37060216

RESUMEN

An environmentally friendly oxidation system has proposed for the practical and scalable production of value-added 2,5-furandicarboxylic acid from 1 kg of 5-hydroxymethylfurfural. The system is composed of a simple base, oxygen, and a green solvent, thereby providing a sustainable and economical approach to organic synthesis. To gain insight into the mechanism of this oxidation process, NMR spectroscopic analysis and kinetic study are used for the mechanistic investigation of this environmentally friendly oxidation process.

3.
Sci Rep ; 13(1): 2148, 2023 02 07.
Artículo en Inglés | MEDLINE | ID: mdl-36750725

RESUMEN

Hemoglobin variability is known to increase cardiovascular mortality in chronic kidney disease, but the association of hemoglobin variability with the risk of cardiovascular disease (CVD) in the general population is yet unclear. This retrospective cohort study based on 'the South Korean National Health Insurance Service database' consisted of 198,347 adults who went through all three health examinations. Hemoglobin variability is defined as the average successive variability of three separate hemoglobin values from each health screening period. Participants were followed up for 6 years to determine the risk of coronary heart disease and stroke. We used multivariate Cox proportional hazards regression to examine the adjusted hazard ratios for CVD according to hemoglobin variability. Per 1 unit increase of hemoglobin variability, the risk for CVD (aHR 1.06, 95% CI 1.02-1.09) and stroke (aHR 1.08, 95% CI 1.03-1.13) increased significantly. The risk-increasing trend was preserved in the low-to-moderate risk group of CVDs (aHR 1.07, 95% CI 1.02-1.11). This result suggests that subjects with high hemoglobin variability who would otherwise be categorized as having low-to-moderate CVD risk may have higher risk of CVD than those with low hemoglobin variability.


Asunto(s)
Enfermedades Cardiovasculares , Hemoglobinas , Adulto , Humanos , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Hemoglobinas/análisis , República de Corea/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Accidente Cerebrovascular/sangre , Accidente Cerebrovascular/epidemiología , Medición de Riesgo
4.
Korean Circ J ; 51(12): 1017-1029, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34595884

RESUMEN

BACKGROUND AND OBJECTIVES: While diuretics are sometimes used in atrial septal defect (ASD) treatment, their effect on ASD size reduction remains unclear. We aimed to evaluate the efficacy of diuretics in ASD size reduction in pediatric patients. METHODS: We retrospectively reviewed the medical records of patients with secundum ASD (size ≥10 mm), between 2005 and 2019. Patients were divided into two groups based on the diuretic administration. RESULTS: Of the 73 enrolled patients, 40 received diuretics. The initial age at ASD diagnosis (2.8±1.7 vs. 2.5±2.0 years, p=0.526) and follow-up duration (22.3±11.4 vs. 18.7±13.2 months, p=0.224) were not significantly different between the groups. The ASD diameter at the initial diagnosis (13.7±2.0 vs. 13.5±3.4 mm, p=0.761) and the indexed ASD diameter (25.5±5.9 vs. 26.9±10.3 mm/m², p=0.493) were also not significantly different between two groups. The ASD diameter significantly increased in the non-diuretic group during follow-up (0.0±2.9 vs. +2.6±2.0 mm, p<0.001). The indexed ASD diameter significantly decreased in the diuretic group during follow-up (-5.7±6.5 vs. +0.2±3.9 mm/m², p<0.001). In the linear mixed model analysis, diuretic use was associated with ASD diameter decrease (p<0.001) and indexed ASD diameter reduction (p<0.001) over time. Device closure was more frequently performed in the diuretic (75.0%) than in the non-diuretic group (39.4%). CONCLUSIONS: Patients receiving diuretics are less likely to undergo surgery. The diuretics administration may be associated with the use of smaller ASD devices for transcatheter treatment through ASD size reduction.

5.
PLoS One ; 15(12): e0234177, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33270634

RESUMEN

To isolate Bacillus velezensis mutants with improved antifungal activity for use in the biological control of phytopathogenic fungi, wild-type Bacillus velezensis KRF-001 producing iturin, surfactin, and fengycin was irradiated by ultraviolet (UV) rays. The in vitro and in vivo antifungal activities of UV mutants and characterization of the cyclic lipopeptides produced by a selected mutant were examined. A mutant strain yielding high levels of iturin showed over 2-fold higher antifungal activity than the wild-type against Fusarium oxysporum. A potent suppressive effect of the mutant was also observed on spore germination of Botrytis cinerea, the causative agent of cucumber gray mold, at different butanol extract concentrations. Further analysis of the mutant by real-time PCR and high-performance liquid chromatography revealed increased expression of iturin and surfactin biosynthesis genes as well as enhanced production of iturin and surfactin metabolites. However, the amounts of fengycin obtained from the mutant strain BSM54 were significantly lesser than those of iturin and surfactin. Particularly, iturin A production by the mutant was 3.5-fold higher than that of the wild-type, suggesting that the higher antifungal activity of the mutant against F. oxysporum resulted from the increased expression of biosynthesis genes associated with iturin production. The commercial greenhouse experiment using soil naturally infested with Sclerotinia sclerotiorum (sclerotinia rot) and F. oxysporum (fusarium wilt) showed that the mutant strain reduced sclerotinia rot and fusarium wilt diseases (P = 0.05) more effectively than the wild-type and commercially available product Cillus® in Korea. These results suggest that the mutant with high iturin yield is a potential candidate for the development of a biological control agent in agriculture.


Asunto(s)
Antifúngicos/aislamiento & purificación , Bacillus/aislamiento & purificación , Péptidos Cíclicos/metabolismo , Ascomicetos/crecimiento & desarrollo , Bacillus/metabolismo , Botrytis/crecimiento & desarrollo , Fusarium/crecimiento & desarrollo , Lipopéptidos/metabolismo , República de Corea
6.
PLoS One ; 12(12): e0188179, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29267290

RESUMEN

Bacillus subtilis subsp. krictiensis ATCC55079 produces the cyclic lipopeptide antibiotics iturin A-F as well as several surfactins. Here, we analyzed and characterized the biosynthetic genes associated with iturin and surfactin production in this strain. We aligned the sequences of each iturin and surfactin synthetase ORF obtained from a genomic library screen and next generation sequencing. The resulting 37,249-bp and 37,645-bp sequences associated with iturin and surfactin production, respectively, contained several ORFs that are predicted to encode proteins involved in iturin and surfactin biosynthesis. These ORFs showed higher sequence homologies with the respective iturin and surfactin synthetase genes of B. methylotrophicus CAU B946 than with those of B. subtilis RB14 and B. subtilis ATCC6633. Moreover, comparative analysis of the secondary metabolites produced by the wild-type and surfactin-less mutant (with a spectinomycin resistance cassette inserted into the srfAB gene within the putative surfactin gene region) strains demonstrated that the mutant strain showed significantly higher antifungal activity against Fusarium oxysporum than the wild-type strain. In addition, the wild-type strain-specific surfactin high performance liquid chromatography (HPLC) peaks were not observed in the surfactin-less mutant strain. In contrast, the iturin A peak detected by HPLC and liquid chromatography-mass spectrometry (LC/MS) in the surfactin-less mutant strain was 30% greater than that in the wild-type strain. These results suggested that the gene cluster we identified is involved in surfactin biosynthesis, and the biosynthetic pathways for iturin and surfactin in Bacillus strains producing both iturin and surfactin may utilize a common pathway.


Asunto(s)
Bacillus subtilis/genética , Genes Bacterianos , Péptidos Cíclicos/biosíntesis , Bacillus subtilis/enzimología , Cromatografía Líquida de Alta Presión , Clonación Molecular , Espectrometría de Masas , Sistemas de Lectura Abierta
7.
J Microbiol Biotechnol ; 27(7): 1272-1275, 2017 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-28535608

RESUMEN

Two dimeric sesquiterpenes were separated from Chloranthus japonicus Sieb. and identified as shizukaols C and F. They exhibited potent antifungal activities (MICs = 4-16 µg/ml) in vitro against various plant pathogenic fungi (Pythium ultimum, Phytophthora infestans, Botrytis cinerea, Colletotrichum lagenarium, Alternaria kikuchiana, and Magnaporthe grisea). Shizukaol C showed 88% and 91% protective activities in the greenhouse against Puccinia recondita (wheat leaf rust) and Phytophthora infestans (tomato late blight), respectively, at 100 µg/ml; shizukaol F exhibited 93% antifungal activity against Puccinia recondita at the same concentration. Therefore, these compounds might serve as interesting candidates for effective antifungal agents.


Asunto(s)
Antifúngicos/farmacología , Hongos/efectos de los fármacos , Magnoliopsida/química , Sesquiterpenos/farmacología , Antifúngicos/química , Antifúngicos/aislamiento & purificación , Fungicidas Industriales/aislamiento & purificación , Fungicidas Industriales/farmacología , Medicina Tradicional China , Pruebas de Sensibilidad Microbiana , Phytophthora infestans/efectos de los fármacos , Enfermedades de las Plantas/prevención & control , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Sesquiterpenos/química , Sesquiterpenos/aislamiento & purificación
8.
BMC Vet Res ; 10: 179, 2014 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-25255918

RESUMEN

BACKGROUND: After the recent outbreak of foot-and-mouth disease (FMD) in Korea, a vaccination policy has been applied to control the disease. In addition, several non-specific immune stimulators have been used without any scientific evidence that they would enhance the immune response after FMD vaccination and/or protect against FMD. Based on the current situation, the aim of this study was to evaluate the effect of the non-specific immune stimulator germanium biotite on FMD vaccination and immune responses in cattle. To achieve our goal, immune responses to FMD vaccination, such as levels of IgG and IgA, antibody duration, and virus-neutralizing titers were investigated after germanium biotite feeding. The PBMC typing and proliferative response after stimulation with mitogens, the cytokines expression level of PBMC, and the lysozyme activity in the serum were measured to evaluate the immune enhancing effects of germanium biotite following its administration. RESULTS: Following the first vaccination, high level of IgG (at 4 weeks) and IgA (at 2 and 31 weeks) titers in serum and saliva were observed in the germanium biotite-feeding group (p < 0.05). The germanium biotite group also showed high and longstanding inhibition percentage value in ELISA assay at 31 weeks (p < 0.05). Generally, higher virus-neutralizing antibody titers were observed in the feeding group at 20 and 31 weeks after vaccination. Following the feeding germanium biotite, the germanium biotite group showed increased subpopulation of CD4+ lymphocytes and MHC I+II+ cells in PBMCs at 23 week, responding to stimulation of ConA. The levels of IFN-γ (at 3 and 8 weeks), IL-1α (at 3, 11, and 23 weeks), IL-1ß (at 3, 8, and 11 weeks), and IL-4 (at 8 and 11 weeks) gene expression were also significantly increased in the feeding group (p < 0.01 and p < 0.05). Feeding with germanium biotite increased the lymphocytes' proliferative response to the stimulation of ConA and LPS at 23 weeks and lysozyme activity at 9 weeks after feeding. CONCLUSIONS: These results suggest that germanium biotite feeding could increase the protection against FMD virus infection via the induction of higher humoral and cellular immune responses in cattle.


Asunto(s)
Enfermedades de los Bovinos/prevención & control , Suplementos Dietéticos , Fiebre Aftosa/prevención & control , Germanio/uso terapéutico , Vacunas Virales/inmunología , Alimentación Animal/análisis , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Bovinos , Enfermedades de los Bovinos/inmunología , Citocinas/genética , Citocinas/metabolismo , Fiebre Aftosa/epidemiología , Regulación de la Expresión Génica/fisiología , Germanio/administración & dosificación , República de Corea/epidemiología , Vacunación/legislación & jurisprudencia
9.
Arch Virol ; 159(12): 3219-30, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25091740

RESUMEN

Classical swine fever (CSF), caused by the CSF virus (CSFV), is a highly contagious disease in pigs. In Korea, vaccination using a live-attenuated strain (LOM strain) has been used to control the disease. However, parenteral vaccination using a live-attenuated strain still faces a number of problems related to storage, cost, injection stress, and differentiation of CSFV infected and vaccinated pigs. Therefore, two kinds of new candidates for oral vaccination have been developed based on the translation of the E2 gene of the SW03 strain, which was isolated from an outbreak of CSF in 2002 in Korea, in transgenic rice calli (TRCs) from Oriza sativa L. cv. Dongjin to express a recombinant E2 protein (rE2-TRCs). The expression of the recombinant E2 protein (rE2) in rE2-TRCs was confirmed using Northern blot, SDS-PAGE, and Western blot analysis. Immune responses to the rE2-TRC in mice and pigs were investigated after oral administration. The administration of rE2-TRCs increased E2-specific antibodies titers and antibody-secreting cells when compared to animals receiving the vector alone (p < 0.05 and p < 0.01). In addition, mice receiving rE2-TRCs had a higher level of CD8+ lymphocytes and Th1 cytokine immune responses to purified rE2 (prE2) in vitro than the controls (p < 0.05 and p < 0.01). Pigs receiving rE2-TRCs also showed an increase in IL-8, CCL2, and the CD8+ subpopulation in response to stimulation with prE2. These results suggest that oral administration of rE2-TRCs can induce E2-specific immune responses.


Asunto(s)
Virus de la Fiebre Porcina Clásica/inmunología , Oryza/genética , Plantas Modificadas Genéticamente , Vacunas Sintéticas/inmunología , Proteínas del Envoltorio Viral/inmunología , Vacunas Virales/inmunología , Administración Oral , Animales , Anticuerpos Antivirales/sangre , Células Productoras de Anticuerpos/inmunología , Linfocitos T CD8-positivos/inmunología , Quimiocina CCL2/metabolismo , Virus de la Fiebre Porcina Clásica/genética , Interleucina-8/metabolismo , Corea (Geográfico) , Ratones , Porcinos , Subgrupos de Linfocitos T/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/aislamiento & purificación , Proteínas del Envoltorio Viral/genética , Vacunas Virales/administración & dosificación , Vacunas Virales/genética , Vacunas Virales/aislamiento & purificación
10.
BMC Genomics ; 14: 426, 2013 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-23802650

RESUMEN

BACKGROUND: Brucella abortus is an intracellular zoonotic pathogen which causes undulant fever, endocarditis, arthritis and osteomyelitis in human and abortion and infertility in cattle. This bacterium is able to invade and replicate in host macrophage instead of getting removed by this defense mechanism. Therefore, understanding the interaction between virulence of the bacteria and the host cell is important to control brucellosis. Previously, we generated internalization defective mutants and analyzed the envelope proteins. The present study was undertaken to evaluate the changes in early transcriptional responses between wild type and internalization defective mutants infected mouse macrophage, RAW 264.7. RESULTS: Both of the wild type and mutant infected macrophages showed increased expression levels in proinflammatory cytokines, chemokines, apoptosis and G-protein coupled receptors (Gpr84, Gpr109a and Adora2b) while the genes related with small GTPase which mediate intracellular trafficking was decreased. Moreover, cytohesin 1 interacting protein (Cytip) and genes related to ubiquitination (Arrdc3 and Fbxo21) were down-regulated, suggesting the survival strategy of this bacterium. However, we could not detect any significant changes in the mutant infected groups compared to the wild type infected group. CONCLUSIONS: In summary, it was very difficult to clarify the alterations in host cellular transcription in response to infection with internalization defective mutants. However, we found several novel gene changes related to the GPCR system, ubiquitin-proteosome system, and growth arrest and DNA damages in response to B. abortus infection. These findings may contribute to a better understanding of the molecular mechanisms underlying host-pathogen interactions and need to be studied further.


Asunto(s)
Brucella abortus/genética , Brucella abortus/fisiología , Macrófagos/microbiología , Mutación/genética , Transcripción Genética , Animales , Línea Celular , Perfilación de la Expresión Génica , Macrófagos/citología , Ratones , Anotación de Secuencia Molecular , Análisis de Secuencia por Matrices de Oligonucleótidos , Reproducibilidad de los Resultados , Factores de Tiempo
11.
Microbiol Immunol ; 57(6): 417-25, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23773020

RESUMEN

An oral delivery system based on ApxIIA#5-expressed on Saccharomyces cerevisiae was studied for its potential to induce immune responses in mice. Murine bone marrow-derived dendritic cells (DCs) stimulated in vitro with ApxIIA#5-expressed on S. cerevisiae upregulated the expression of maturation and activation markers, leading to production of tumor necrosis factor-α, interleukin (IL)-1ß, IL-12p70 and IL-10. Presentation of these activated DCs to cluster of differentiation CD4+ T cells collected from mice that had been orally immunized with the ApxIIA#5-expressed on S. cerevisiae elicited specific T-cell proliferation. In addition, the orally immunized mice had stronger antigen-specific serum IgG and IgA antibody responses and larger numbers of antigen-specific IgG and IgA antibody-secreting cells in their spleens, Peyer's patches and lamina propria than did those immunized with vector-only S. cerevisiae or those not immunized. Furthermore, oral immunization induced T helper 1-type immune responses mediated via increased serum concentrations of IgG2a and an increase predominantly of IFN-γ-producing cells in their spleens and lamina propria. Our findings suggest that surface-displayed ApxIIA#5-expressed on S. cerevisiae may be a promising candidate for an oral vaccine delivery system for eliciting systemic and mucosal immunity.


Asunto(s)
Infecciones por Actinobacillus/prevención & control , Actinobacillus pleuropneumoniae/inmunología , Proteínas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Proteínas Hemolisinas/inmunología , Saccharomyces cerevisiae/inmunología , Infecciones por Actinobacillus/inmunología , Actinobacillus pleuropneumoniae/genética , Administración Oral , Animales , Anticuerpos Antibacterianos/sangre , Proteínas Bacterianas/genética , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/genética , Linfocitos T CD4-Positivos/inmunología , Proliferación Celular , Citocinas/metabolismo , Células Dendríticas/inmunología , Proteínas Hemolisinas/genética , Inmunidad Mucosa , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Ratones , Saccharomyces cerevisiae/genética
12.
Vet Immunol Immunopathol ; 151(1-2): 132-9, 2013 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-23206402

RESUMEN

Actinobacillus pleuropneumoniae is a causative agent of porcine pleuropneumonia, a highly contagious endemic disease of pigs worldwide, inducing significant economic losses worldwide. Apx toxins, which are correlated with the virulence of A. pleuropneumoniae, were expressed in Saccharomyces cerevisiae and its possible use as an oral vaccine has been confirmed in our previous studies using a murine model. The present study was undertaken to test the hypothesis that oral immunization using S. cerevisiae expressing either ApxI or ApxII could protect pigs against A. pleuropneumoniae as an effective way of inducing both mucosal and systemic immune responses. The surface-displayed ApxIIA#5 expressing S. cerevisiae was selected as an oral vaccine candidate by finding on induction of higher immune responses in mice after oral vaccination. The surface-displayed ApxIIA#5 expressing S. cerevisiae and the ApxIA expressing S. cerevisiae were developed to serve as an oral vaccine in pigs. The vaccinated pigs showed higher specific IgG- and IgA-related antibody activities than the non-treated control and vector control pigs. Additionally, the induced immune responses were found to protect pigs infected with A. pleuropneumoniae according to the analysis of clinical signs and the gross and microscopic pulmonary lesions. These results suggested that the surface-displayed ApxIIA#5 and ApxIA in S. cerevisiae might be a potential oral vaccine to protect pigs against porcine pleuropneumonia. Thus the present study is expected to contribute to the development of a live oral vaccine against porcine pleuropneumonia as an alternative to current conventional vaccines.


Asunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae/inmunología , Proteínas Bacterianas/administración & dosificación , Proteínas Hemolisinas/administración & dosificación , Pleuroneumonía Contagiosa/inmunología , Pleuroneumonía Contagiosa/prevención & control , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/prevención & control , Infecciones por Actinobacillus/inmunología , Infecciones por Actinobacillus/microbiología , Infecciones por Actinobacillus/prevención & control , Actinobacillus pleuropneumoniae/genética , Actinobacillus pleuropneumoniae/patogenicidad , Administración Oral , Secuencia de Aminoácidos , Animales , Anticuerpos Antibacterianos/biosíntesis , Proteínas Bacterianas/genética , Proteínas Bacterianas/inmunología , Toxinas Bacterianas/administración & dosificación , Toxinas Bacterianas/genética , Toxinas Bacterianas/inmunología , Vacunas Bacterianas/administración & dosificación , Secuencia de Bases , ADN Bacteriano/genética , Femenino , Proteínas Hemolisinas/genética , Proteínas Hemolisinas/inmunología , Pulmón/inmunología , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Pleuroneumonía Contagiosa/microbiología , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/inmunología , Sus scrofa , Porcinos , Enfermedades de los Porcinos/microbiología , Vacunación/veterinaria , Vacunas Sintéticas/administración & dosificación
13.
J Vet Sci ; 14(4): 467-72, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24421718

RESUMEN

Swine hepatitis E virus (HEV) is widespread throughout pigs in both developing and industrialized countries. This virus is an important zoonotic agent and a public concern worldwide. Infected pigs are asymptomatic, so diagnosing swine HEV relies on detection of the virus or antibodies against the virus. However, several obstacles need to be overcome for effective and practical serological diagnosis. In this study, we developed an enzyme-linked immunosorbent assay (ELISA) that used a purified recombinant capsid protein of swine HEV. The potential clinical use of this assay was evaluated by comparing it with a commercial kit (Genelabs Technologies, Diagnostics, Singapore). Results of the ELISA were highly correlated with those of the commercial kit with a sensitivity of 97% and specificity of 95%. ROC (receiving operator characteristic) analysis of the ELISA data produced a value of 0.987 (95% CI, 0.977~0.998, p < 0.01). The cut-off value for the ELISA was also determined using negative pig sera. In summary, the HEV-specific ELISA developed in the present study appears to be both practical and economical.


Asunto(s)
Anticuerpos Antiidiotipos/análisis , Proteínas de la Cápside/genética , Ensayo de Inmunoadsorción Enzimática/métodos , Virus de la Hepatitis E/aislamiento & purificación , Hepatitis E/veterinaria , Enfermedades de los Porcinos/diagnóstico , Animales , Anticuerpos Antiidiotipos/sangre , Anticuerpos Antiidiotipos/genética , Proteínas de la Cápside/metabolismo , Ensayo de Inmunoadsorción Enzimática/veterinaria , Hepatitis E/diagnóstico , Hepatitis E/inmunología , Hepatitis E/virología , Virus de la Hepatitis E/genética , Virus de la Hepatitis E/metabolismo , Inmunoglobulina G/sangre , Inmunoglobulina G/genética , Curva ROC , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Porcinos , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/virología
14.
J Vet Med Sci ; 74(8): 1037-9, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22446401

RESUMEN

We evaluated effect of enterotoxigenic Escherichia coli (ETEC) specific lytic phage CJ12 in ETEC infected pigs. Phage was mixed with feed at a ratio of 1:1,000 (0.1%). One week after initially providing phage mixed feed, pigs were challenged orally with 10(11) CFU of ETEC and body weight, diarrhea score, bacterial CFU and phage PFU in the feces were measured. Pigs of phage treated groups C (10(6) PFU/g) and D (10(8) PFU/g) showed more resistance to diarrhea due to ETEC infection compared to positive control group B on the third day after the initial challenge. Moreover, during the quantitation of ETEC in feces, both groups C and D showed approximately 63.92 and 60.73% reduced ETEC compared to positive control group B. Phages were successfully isolated from feces in both groups C and D during the experiment without any adverse effects, suggesting the possibility of using CJ12 as a feed additive.


Asunto(s)
Bacteriófagos/fisiología , Escherichia coli Enterotoxigénica/virología , Infecciones por Escherichia coli/veterinaria , Enfermedades de los Porcinos/microbiología , Alimentación Animal , Animales , Diarrea/microbiología , Diarrea/veterinaria , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/prevención & control , Heces/microbiología , Porcinos , Enfermedades de los Porcinos/prevención & control
15.
Eur J Pharm Biopharm ; 81(1): 43-8, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22306699

RESUMEN

A vaccine delivery system based on thiolated eudragit microsphere (TEMS) was studied in vivo for its ability to elicit mucosal immunity against enterotoxigenic Escherichia coli (ETEC). Groups of mice were orally immunized with F4 or F18 fimbriae of ETEC and F4 or F18 loaded in TEMS. Mice that were orally administered with F4 or F18 loaded TEMS showed higher antigen-specific IgG antibody responses in serum and antigen-specific IgA in saliva and feces than mice that were immunized with antigens only. In addition, oral vaccination of F4 or F18 loaded TEMS resulted in higher numbers of IgG and IgA antigen-specific antibody secreting cells in the spleen, lamina propria, and Peyer's patches of immunized mice than other groups. Moreover, TEMS administration loaded with F4 or F18 induced mixed Th1 and Th2 type responses based on similarly increased levels of IgG1 and IgG2a. These results suggest that F4 or F18 loaded TEMS may be a promising candidate for an oral vaccine delivery system to elicit systemic and mucosal immunity against ETEC.


Asunto(s)
Escherichia coli Enterotoxigénica/inmunología , Infecciones por Escherichia coli/inmunología , Ácidos Polimetacrílicos/química , Vacunas/inmunología , Administración Oral , Animales , Antígenos Bacterianos/administración & dosificación , Antígenos Bacterianos/inmunología , Proteínas de Escherichia coli/administración & dosificación , Proteínas de Escherichia coli/inmunología , Femenino , Proteínas Fimbrias/administración & dosificación , Proteínas Fimbrias/inmunología , Inmunidad Mucosa , Inmunoglobulina A/inmunología , Inmunoglobulina G/inmunología , Ratones , Ratones Endogámicos ICR , Microesferas , Compuestos de Sulfhidrilo/química , Vacunas/administración & dosificación
16.
FEMS Immunol Med Microbiol ; 64(2): 244-54, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22066675

RESUMEN

Brucella abortus is a facultative intracellular bacteria that replicates within a macrophage without producing any classical virulence factors. It can become internalized to cells by zipper-like and/or swimming internalization mechanisms. However, the bacterial proteins involved in internalization remain unclear. To define these bacterial proteins, random insertion mutants of B. abortus were generated by the Tn5 transposome complexes. In all, 132 mutants were screened, cellular internalization-defective mutants were selected, and these genomic and envelope proteomic features were identified. The transposon insertion sites were ccmC,ppk and BruAb2_0168 for the mutant C10, C29 and D7, respectively. Mutant C10 showed a deficiency in internalization without any changes in expression of the cell envelope proteins; however, mutant C29 showed a reduced expression of OMP25, and a mutant D7 also showed reduced expression of OMP25, OMP28 and Porin2b. These results suggest OMP25 is not an essential factor, but might be involved in host cellular internalization. We identified the ppk gene and BruAb2_0168 locus which are associated to expression of OMP25, OMP28 and Porin2b as well as pleiotropic effects of ccmC gene.


Asunto(s)
Brucella abortus/fisiología , Macrófagos/microbiología , Proteínas de la Membrana/genética , Fagocitos/microbiología , Animales , Southern Blotting , Brucella abortus/genética , Brucella abortus/metabolismo , Línea Celular , Electroforesis en Gel de Campo Pulsado , Electroforesis en Gel Bidimensional , Genes Bacterianos , Interacciones Huésped-Patógeno , Ratones , Mutación , Fosfotransferasas (Aceptor del Grupo Fosfato)/genética , Porinas/metabolismo
17.
J Vet Sci ; 12(4): 401-3, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22122907

RESUMEN

Corn, one of the most important forage crops worldwide, has proven to be a useful expression vehicle due to the availability of established transformation procedures for this well-studied plant. The exotoxin Apx, a major virulence factor, is recognized as a common antigen of Actinobacillus (A.) pleuropneumoniae, the causative agent of porcine pleuropneumonia. In this study, a cholera toxin B (CTB)-ApxIIA#5 fusion protein and full-size ApxIIA expressed in corn seed, as a subunit vaccine candidate, were observed to induce Apx-specific immune responses in mice. These results suggest that transgenic corn-derived ApxIIA and CTB-ApxIIA#5 proteins are potential vaccine candidates against A. pleuropneumoniae infection.


Asunto(s)
Infecciones por Actinobacillus/prevención & control , Proteínas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Toxina del Cólera/química , Proteínas Hemolisinas/inmunología , Zea mays/genética , Infecciones por Actinobacillus/microbiología , Actinobacillus pleuropneumoniae , Animales , Antígenos Bacterianos/inmunología , Femenino , Inmunización Secundaria , Ratones , Ratones Endogámicos ICR , Plantas Modificadas Genéticamente
18.
J Vet Diagn Invest ; 23(4): 736-42, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21908316

RESUMEN

Actinobacillus pleuropneumoniae is the etiologic agent of porcine pleuropneumonia, a highly contagious pulmonary disease in pigs with major economic losses for pig producers worldwide. Whereas A. pleuropneumoniae isolates are divided into 15 serotypes, the isolates secrete 4 types of exotoxins (ApxI, ApxII, ApxIII, and ApxIV), which are known as major virulence factors. In the current study, the ApxIA, ApxIIA, and ApxIIIA genes were amplified and their recombinant proteins expressed in Escherichia coli M15 cells. The antigenicity of each recombinant protein was demonstrated by Western blot and enzyme-linked immunosorbent assay (ELISA) using sera from pigs vaccinated with a subunit vaccine. When ELISAs using the recombinant antigens were optimized and then applied to sera from 320 randomized pigs in Korea, an observed increase in seroprevalence was found among sows in comparison with weaned piglets and growing pigs, indicating an age-dependent seroprevalence. The results obtained in the study suggest that the developed ELISAs may be useful for A. pleuropneumoniae vaccination strategy as a screening tool for pig herds as well as for detection of specific antibodies to Apx exotoxins.


Asunto(s)
Infecciones por Actinobacillus/veterinaria , Actinobacillus pleuropneumoniae/metabolismo , Proteínas Bacterianas/aislamiento & purificación , Proteínas Hemolisinas/aislamiento & purificación , Técnicas de Inmunoadsorción/veterinaria , Infecciones por Actinobacillus/diagnóstico , Infecciones por Actinobacillus/epidemiología , Infecciones por Actinobacillus/inmunología , Infecciones por Actinobacillus/microbiología , Actinobacillus pleuropneumoniae/aislamiento & purificación , Animales , Anticuerpos Antibacterianos/sangre , Inmunoglobulina G/sangre , Proteínas Recombinantes , República de Corea/epidemiología , Estudios Seroepidemiológicos , Porcinos , Enfermedades de los Porcinos/diagnóstico , Enfermedades de los Porcinos/epidemiología , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/microbiología
19.
J Microbiol ; 49(3): 462-8, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21717333

RESUMEN

Actinobacillus pleuropneumoniae causes a severe hemorrhagic pneumonia in pigs. Fifteen serotypes of A. pleuropneumoniae express four different Apx toxins that belong to the pore-forming repeats-in-toxin (RTX) group of toxins. ApxIV, which is conserved and up-regulated in vivo, could be an excellent candidate for the development of a protective cross-serotype immunity vaccine, and could aid in the differential diagnosis of diseases caused by A. pleuropneumoniae. We identified and sequenced apxIVA from A. pleuropneumoniae serotype 2 isolated in Korea (Kor-ApxIVA). The Kor-ApxIVA was closely related to Switzerland (AF021919), China (CP000687), and China (GQ332268), showing 98.6%, 98.4%, and 97.2% amino acid homology, respectively. The level of amino acid homology, however, was higher than the nucleotide homology. The structural characteristics of ApxIVA showed RTX proteins, including N-terminal hydrophobic domains, signature sequences for potential acylation sites, and repeated glycine-rich nonapeptides in the C-terminal region of the protein. Thirty glycine-rich nonapeptides with the consensus sequence, L/V-X-G-G-X-G-N/D-D-X, were found in the C-terminus of the Kor-ApxIVA. In addition, the Kor-ApxIVA was predicted for the linear B-cell epitopes and conserved domains with determined peptide sequences. This genetic analysis of the Kor-ApxIVA might be an important foundation for future biological and functional research on ApxIVA.


Asunto(s)
Infecciones por Actinobacillus/microbiología , Actinobacillus pleuropneumoniae/genética , Actinobacillus pleuropneumoniae/inmunología , Proteínas Bacterianas/genética , Proteínas Bacterianas/inmunología , Epítopos de Linfocito B/inmunología , Actinobacillus pleuropneumoniae/clasificación , Actinobacillus pleuropneumoniae/metabolismo , Animales , Proteínas Bacterianas/química , Mapeo Epitopo , Datos de Secuencia Molecular , Filogenia , República de Corea , Análisis de Secuencia de ADN , Serotipificación , Enfermedades de los Porcinos/microbiología
20.
Eur J Pharm Biopharm ; 79(2): 226-31, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21571066

RESUMEN

Diarrhea in newborn and weaned piglets is mainly induced by enterotoxigenic Escherichia coli (ETEC) with fimbriae F4 (K88) and F18 (F107). In this study, we evaluated F4 and F18 coated with thiolated Eudragit microspheres (TEMS) as a candidate for an oral vaccine. The average particle sizes of TEMS, F4-loaded TEMS, and F18-loaded TEMS were measured as 4.2±0.75 µm, 4.7±0.50 µm, and 4.5±0.37 µm, respectively. F4 is more efficiently encapsulated than F18 in the loading with TEMS. In the release test, F4 and F18 fimbriae were protected in acidic circumstances, whereas most were released at pH 7.4 of intestine circumstances. Production of TNF-α and NO from RAW 264.7 cells was increased in a time-dependent manner after exposure to all groups, whereas only F4- or F18-loaded TEMS-stimulated IL-6 secretion. The levels of IFN-γ from mouse splenocytes after exposure to F4 or F18 were increased while IL-4 was not detectable. These results suggest that F4- and F18-loaded TEMS may effectively induce immune response with the efficient release of antigens to appropriate target sites.


Asunto(s)
Vacunas Bacterianas/inmunología , Escherichia coli Enterotoxigénica/inmunología , Infecciones por Escherichia coli/inmunología , Proteínas Fimbrias/inmunología , Fimbrias Bacterianas/inmunología , Ácidos Polimetacrílicos/farmacología , Células TH1/inmunología , Animales , Antígenos Bacterianos/inmunología , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/química , Línea Celular , Infecciones por Escherichia coli/prevención & control , Femenino , Interleucina-4/inmunología , Interleucina-6/inmunología , Mucosa Intestinal/inmunología , Ratones , Ratones Endogámicos ICR , Microesferas , Óxido Nítrico/inmunología , Ácidos Polimetacrílicos/química , Factor de Necrosis Tumoral alfa/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA